Search articles in Pharma Appointments

Filter Articles

Open filters

Sections

Found 1,274 articles

Highly experienced CDMO expert Michel Spagnol appointed Chairman of Astraveus
- 28 Nov 2023
- PharmiWeb Editor
Astraveus SAS, the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT) manufacturing, today announces the appointment of Michel Spagnol as its new Chairman of the Board.
Mentice appoints Ulrika Drotz Voksepp as new Chief Financial Officer
- 23 Nov 2023
- Editor
Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, appoints Ulrika Drotz Voksepp as CFO, effective January 2nd, 2024
Boris Bachmeier appointed new Managing Director of Romaco Pharmatechnik GmbH
- 23 Nov 2023
- Editor
Boris Bachmeier has been appointed new Managing Director of Romaco Pharmatechnik GmbH in Karlsruhe. He succeeds Markus Regner, who will be leaving the company at his own request at the end of November.
OMass Therapeutics expands leadership team with the appointment of Melissa Faris as Chief Business Officer
- 16 Nov 2023
- Editor
OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the appointment of Melissa Faris as Chief Business Officer, effective immediately.
Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors
- 16 Nov 2023
- Editor
Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), today announces the appointment of Dr Chris Martin as independent Chairman to its Board of Directors.
Exciting Leadership Announcement: huumun welcomes James Karcher as Chief Commercial Officer
- 16 Nov 2023
- Editor
We are pleased to announce the appointment of James Karcher as Chief Commercial Officer (CCO) at huumun. With a strong background in marketing and communications, James has a proven track record of delivering effective client solutions and fostering long-term business relationships.
eXmoor appoints Matthew Paterson as first Chief Commercial Officer
- 16 Nov 2023
- Editor
eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, announced the hiring of Matthew Paterson as the company’s first Chief Commercial Officer, to spearhead the company’s growth and international footprint as it expands its contract development and manufacturing services for CGTs.
Tessellate BIO, an Emerging Precision Oncology Company Announces the Appointment of World-Leading Scientists to its Scientific Advisory Board
- 15 Nov 2023
- Editor
Tessellate BIO, a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches, today announces the appointment of multiple international experts to its Scientific Advisory Board.
Oxolife Appoints International Fertility Experts to its Scientific Advisory Board
- 14 Nov 2023
- Editor
Oxolife, the specialist biotech focused on enhancing embryo implantation in women undergoing Assisted Reproductive Technology (ART) fertility treatment, today announces it has appointed globally renowned fertility experts to its Scientific Advisory Board (SAB).
IO Biotech Appoints Helen Collins, MD, to its Board of Directors
- 14 Nov 2023
- Editor
IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating cancer vaccines based on its T-win® technology platform, announced the appointment of Helen Collins, MD, to its board of directors.
Axplora announces the appointment of its Scientific Advisory Board
- 14 Nov 2023
- Editor
Axplora, a leading partner to Pharma companies and Biotechs for complex APIs, is pleased to introduce its Scientific Advisory Board, reflecting the innovation mindset embedded in its origins as Farmabios, Novasep and PharmaZell.
PM Society announces new Chair for 2024
- 9 Nov 2023
- Editor
The PM Society has appointed Dom Marchant, Chief Creative Officer at OPEN Health, as Chair, to succeed Co-chairs Caroline Benson of Cuttsy + Cuttsy and Colin Williams from Astellas. Dom has been part of the PM Society Executive team for seven years, leading on the Creativity for Good initiative which links charities with pro bono creative partners.
Appointment of Non-Executive Directors
- 7 Nov 2023
- Editor
Alliance Pharma plc (AIM: APH), the international healthcare group, is pleased to announce the appointment of Eva-Lotta Sjöstedt and Richard McKenzie as new independent Non-Executive Directors to strengthen the Board and support the delivery of the Company's growth strategy. Both Eva-Lotta and Richard will join the Board with immediate effect.
Royal Orthopaedic Hospital Welcomes Mayor of West Midlands, Andy Street
- 7 Nov 2023
- Editor
Andy Street, Mayor of the West Midlands visited the Royal Orthopaedic Hospital, in Northfield, to learn more about wellbeing work at the Trust, and how colleagues are being supported as part of the West Midlands Combined Authority (WMCA) Thrive at Work programme.
MedX Announces the Appointment of Jeffrey Morris as VP of Sales and Marketing
- 3 Nov 2023
- Editor
MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce the appointment of veteran healthcare industry leader Jeffrey Morris as Vice President of Sales and Marketing.
BioMarin Announces Retirement of Jean-Jacques Bienaimé; Appoints Alexander Hardy President and Chief Executive Officer
- 2 Nov 2023
- Editor
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, announced today that Alexander Hardy has been named president and chief executive officer, succeeding Jean-Jacques Bienaimé, who will retire as chairman and CEO effective December 1, 2023. Mr. Hardy, currently the CEO of Genentech, will also serve as a director on BioMarin's board of directors.
STORM Therapeutics Appoints Marguerite Hutchinson, J.D., as Chief Business Officer
- 1 Nov 2023
- Editor
STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases, is pleased to announce the appointment of Marguerite Hutchinson, J.D., as Chief Business Officer.
Bristol Myers Squibb Appoints Christopher Boerner, Ph.D., to Chair of the Board of Directors, Effective April 1, 2024
- 1 Nov 2023
- Editor
Bristol Myers Squibb (NYSE: BMY) announced that its Board of Directors has unanimously elected Christopher Boerner, Ph.D., to serve as Chair of the Board, effective April 1, 2024. He succeeds Giovanni Caforio, M.D., who will step down as Chair of the Board on April 1, 2024 and retire from the company after 23 years of service.
AAVantgarde Appoints Michael Heffernan as Chairman of its Board of Directors
- 31 Oct 2023
- Editor
AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today announced the appointment of Michael Heffernan as Chairman of the Board with immediate effect.
Dr. Björn Beckmann Appointed Head of Quality Control at Laupheim Site
- 31 Oct 2023
- Editor
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that Dr. Björn Beckmann has been promoted to Head of Quality Control for the Company’s site in Laupheim, Germany, effective October 1, 2023. In this new role, he is responsible for all aspects of quality control (QC).